Gadoxetic acid–enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma

INTRODUCTION: Gadoxetic acid–enhanced magnetic resonance imaging (MRI) contributes to evaluating the prognosis of small hepatocellular carcinoma (sHCC) following treatment. We have investigated the potential role of gadoxetic acid–enhanced MRI based on LI-RADS (Liver Imaging Reporting and Data Syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruizhi, Xu, Hengtian, Chen, Wufei, Jin, Liang, Ma, Zhuangxuan, Wen, Lei, Wang, Hongwei, Cao, Kun, Du, Xia, Li, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932892/
https://www.ncbi.nlm.nih.gov/pubmed/36816925
http://dx.doi.org/10.3389/fonc.2023.975216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932892/
https://www.ncbi.nlm.nih.gov/pubmed/36816925
http://dx.doi.org/10.3389/fonc.2023.975216

Ejemplares similares